These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 11339654)

  • 21. Genetic characteristics and follow-up of patients with fatty acid β-oxidation disorders through expanded newborn screening in a Northern Chinese population.
    Wang S; Leng J; Diao C; Wang Y; Zheng R
    J Pediatr Endocrinol Metab; 2020 May; 33(6):683-690. PubMed ID: 32447334
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fatty acid mitochondrial beta-oxidation and hypoglycaemia in children.
    Taroni F; Uziel G
    Curr Opin Neurol; 1996 Dec; 9(6):477-85. PubMed ID: 9007409
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of Metabolic Defects in Fatty Acid Oxidation Using Peripheral Blood Mononuclear Cells Loaded with Deuterium-Labeled Fatty Acids.
    Yuasa M; Hata I; Sugihara K; Isozaki Y; Ohshima Y; Hara K; Tajima G; Shigematsu Y
    Dis Markers; 2019; 2019():2984747. PubMed ID: 30881520
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selective Screening of Fatty Acids Oxidation Defects and Organic Acidemias by Liquid Chromatography/tandem Mass Spectrometry Acylcarnitine Analysis in Brazilian Patients.
    Vargas CR; Ribas GS; da Silva JM; Sitta A; Deon M; de Moura Coelho D; Wajner M
    Arch Med Res; 2018 Apr; 49(3):205-212. PubMed ID: 30119976
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative plasma acylcarnitine analysis using electrospray tandem mass spectrometry for the diagnosis of organic acidaemias and fatty acid oxidation defects.
    Vreken P; van Lint AE; Bootsma AH; Overmars H; Wanders RJ; van Gennip AH
    J Inherit Metab Dis; 1999 May; 22(3):302-6. PubMed ID: 10384392
    [No Abstract]   [Full Text] [Related]  

  • 26. Update on mitochondrial fatty acid oxidation disorders.
    Spiekerkoetter U; Mayatepek E
    J Inherit Metab Dis; 2010 Oct; 33(5):467-8. PubMed ID: 20842433
    [No Abstract]   [Full Text] [Related]  

  • 27. Selective screening for fatty acid oxidation disorders by tandem mass spectrometry: difficulties in practical discrimination.
    Shigematsu Y; Hirano S; Hata I; Tanaka Y; Sudo M; Tajima T; Sakura N; Yamaguchi S; Takayanagi M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Jul; 792(1):63-72. PubMed ID: 12828998
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical aspects of short-chain acyl-CoA dehydrogenase deficiency.
    van Maldegem BT; Wanders RJ; Wijburg FA
    J Inherit Metab Dis; 2010 Oct; 33(5):507-11. PubMed ID: 20429031
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inborn errors of metabolism diagnosed in sudden death cases by acylcarnitine analysis of postmortem bile.
    Rashed MS; Ozand PT; Bennett MJ; Barnard JJ; Govindaraju DR; Rinaldo P
    Clin Chem; 1995 Aug; 41(8 Pt 1):1109-14. PubMed ID: 7628085
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fatty acid oxidation disorders: maternal health and neonatal outcomes.
    Rector RS; Ibdah JA
    Semin Fetal Neonatal Med; 2010 Jun; 15(3):122-8. PubMed ID: 19926542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and biological features at diagnosis in mitochondrial fatty acid beta-oxidation defects: a French pediatric study of 187 patients.
    Baruteau J; Sachs P; Broué P; Brivet M; Abdoul H; Vianey-Saban C; Ogier de Baulny H
    J Inherit Metab Dis; 2013 Sep; 36(5):795-803. PubMed ID: 23053472
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selective newborn screening of inborn errors of amino acids, organic acids and fatty acids metabolism in the Kingdom of Bahrain.
    Golbahar J; Al-Jishi EA; Altayab DD; Carreon E; Bakhiet M; Alkhayyat H
    Mol Genet Metab; 2013; 110(1-2):98-101. PubMed ID: 23916421
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Defects of mitochondrial beta-oxidation: a growing group of disorders.
    Vockley J; Whiteman DA
    Neuromuscul Disord; 2002 Mar; 12(3):235-46. PubMed ID: 11801395
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The clinical manifestation of MCAD deficiency: challenges towards adulthood in the screened population.
    Schatz UA; Ensenauer R
    J Inherit Metab Dis; 2010 Oct; 33(5):513-20. PubMed ID: 20532824
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fatty acid oxidation disorders: outcome and long-term prognosis.
    Wilcken B
    J Inherit Metab Dis; 2010 Oct; 33(5):501-6. PubMed ID: 20049534
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fifty years of research on mitochondrial fatty acid oxidation disorders: The remaining challenges.
    Vianey-Saban C; Guffon N; Fouilhoux A; Acquaviva C
    J Inherit Metab Dis; 2023 Sep; 46(5):848-873. PubMed ID: 37530674
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Defects in mitochondrial fatty acid oxidation: clinical presentations and their role in sudden infant death.
    Pollitt RJ
    Padiatr Padol; 1993; 28(1):13-7. PubMed ID: 8446423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disorders of fatty acid oxidation.
    Tein I
    Handb Clin Neurol; 2013; 113():1675-88. PubMed ID: 23622388
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathophysiology of fatty acid oxidation disorders.
    Bennett MJ
    J Inherit Metab Dis; 2010 Oct; 33(5):533-7. PubMed ID: 20824345
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of carnitine and fatty acid oxidation and its defects in infantile epilepsy.
    Tein I
    J Child Neurol; 2002 Dec; 17 Suppl 3():3S57-82; discussion 3S82-3. PubMed ID: 12597056
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.